Iron chelators reduce prostaglandins and leukotrienes by inhibiting cyclooxygenase and lipoxygenase: A hypothesis to attenuate PPARγ transcriptional activity in prostate cancer

Medical Hypotheses 2026

View at publisher
Authors: Egarit Noulsri, Surada Lerdwana
DOI: 10.1016/j.mehy.2026.111895
Cited by: 0
References: 38

Fields of Study & Subjects

Cancer Lipids and Metabolism Peroxisome Proliferator-Activated Receptors Inflammatory mediators and NSAID effects

Publication details

Journal / source
Medical Hypotheses
Volume
208
Pages
111895–111895
Publication date
29 January 2026
Language
EN